Three-tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD)

Affiliations

¹ Department of Molecular Genetics, City of Hope National Medical Center, Duarte, California.
² Department of Neurology, Ohio State University Medical Center, Columbus, Ohio.
³ Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Jin Yan et al. Hum Mutat. 2004 Feb.

. 2004 Feb;23(2):203-204.

doi: 10.1002/humu.10307.

¹ Department of Molecular Genetics, City of Hope National Medical Center, Duarte, California.
² Department of Neurology, Ohio State University Medical Center, Columbus, Ohio.
³ Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

No abstract available

References

1. Beggs AH, Koenig M, Boyce FM, Kunkel LM. 1990. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 86:45-48.
1. Buzin CH, Wen CY, Nguyen VQ, Nozari G, Mengos A, Li X, Chen JS, Liu Q, Gatti RA, Fujimura FK, Sommer SS. 2000. Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: evidence that the scanning conditions are generic. Biotechniques 28:746-753.
1. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. 1988. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acid Res 16:11141-11156.
1. Den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, Wapenaar MC, van Paassen HM, Van Broeckhoven C, Pearson PL, van Ommen GJ. 1989. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835-847.
1. Gille JJ, Hogervorst FB, Pals G, Wijnen JT, van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, de Jong D, McElgunn CJ, Schouten JP, Menko FH. 2002. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892-897.